Skip to main navigation Skip to search Skip to main content

Mb130-068 (Falcon 1) - A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Bms-986036 (Peg-Fgf21) In Adults With Nonalcoholic Steatohepatitis (Nash) And Stage 3 Liver Fibrosis

Project: Research

Project Details

StatusFinished
Effective start/end date02/21/19 → 06/30/23

Funding

  • Pharmaceutical Research Associates Incorporated: $82,010.00